Sygnis SunScript Reverse Transcriptases
Sygnis has launched SunScript RT RNaseH+ and SunScript RT RNaseH- enzymes for PCR analysis and the construction of cDNA libraries for use in applications such as next-generation sequencing. The products are based on the company's new SunScript engineered reverse transcriptase, which is derived from HIV-1 and provides extreme thermostability, allowing RT reactions to take place at elevated temperatures of up to 85˚C. Additional advantages include high reaction speed and sensitivity, and the ability to readily transcribe even the longest RNAs from the mammalian genome, Sygnis noted.